Cargando…
Imatinib and Nilotinib Inhibit Hematopoietic Progenitor Cell Growth, but Do Not Prevent Adhesion, Migration and Engraftment of Human Cord Blood CD34(+) Cells
BACKGROUND: The availability of tyrosine kinase inhibitors (TKIs) has considerably changed the management of Philadelphia chromosome positive leukemia. The BCR-ABL inhibitor imatinib is also known to inhibit the tyrosine kinase of the stem cell factor receptor, c-Kit. Nilotinib is 30 times more pote...
Autores principales: | Belle, Ludovic, Bruck, France, Foguenne, Jacques, Gothot, André, Beguin, Yves, Baron, Frédéric, Briquet, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527577/ https://www.ncbi.nlm.nih.gov/pubmed/23285088 http://dx.doi.org/10.1371/journal.pone.0052564 |
Ejemplares similares
-
The Spindle Assembly Checkpoint Is Required for Hematopoietic Progenitor Cell Engraftment
por: Brown, Andreas, et al.
Publicado: (2017) -
The Involvment of Hematopoietic-Specific PLC -β2 in Homing and Engraftment of Hematopoietic Stem/Progenitor Cells
por: Adamiak, Mateusz, et al.
Publicado: (2016) -
Bone Marrow Homing and Engraftment Defects of Human Hematopoietic Stem and Progenitor Cells
por: Caocci, Giovanni, et al.
Publicado: (2017) -
CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation
por: ALADAĞ, Elifcan, et al.
Publicado: (2020) -
Human Cytomegalovirus Infection Suppresses CD34(+) Progenitor Cell Engraftment in Humanized Mice
por: Crawford, Lindsey B., et al.
Publicado: (2020)